Details
| Translated title of the contribution | Cost analysis for ambulatory treatment of cystic fibrosis patients in Germany. Overview of the prospective study results: Overview of the Prospective Study Results |
|---|---|
| Original language | Multiple languages |
| Pages (from-to) | 529-535 |
| Number of pages | 7 |
| Journal | Medizinische Klinik |
| Volume | 104 |
| Issue number | 7 |
| Publication status | Published - Jul 2009 |
Abstract
Purpose: : Main objective of this study is to assess and evaluate resourceuse in outpatient treatment of cystic fibrosis (CF) in Germany and to comparethis with current reimbursement. Methods: Results: Conclusion: Key Words: MedKlin 2009;104:529-35. Methods: : Outpatient treatment was evaluated in sevendifferent CF centers.Clinical patient data, resource use, and time consumptionwere recorded in 2006. A micro-costing approach was used to price resource usedata. Results: : Mean costs of 488 Euros per patient (n = 326) and quarteroccurred. Remuneration (252 Euros per patient/quarter) covered only 52% of thetotal costs. Furthermore, a considerable time and financial burden for patientsas well as decreasing quality of life with increasing age were found. Costs formedication came to 21,604 Euros per patient/year. Conclusion: : Human resourcesin German CF centers today already are below the requirements set by theEuropean consensus for standards of CF care. It will be crucial in assuring ahigh level of patient care to reach a cost-covering reimbursement scheme in Germany.
ASJC Scopus subject areas
- Medicine(all)
- General Medicine
Cite this
- Standard
- Harvard
- Apa
- Vancouver
- BibTeX
- RIS
In: Medizinische Klinik, Vol. 104, No. 7, 07.2009, p. 529-535.
Research output: Contribution to journal › Review article › Research › peer review
}
TY - JOUR
T1 - Evaluation von Kosten der ambulanten Behandlung bei Mukoviszidose in Deutschland
T2 - Übersicht über die Ergebnisse einer prospektiven Studie
AU - Eidt, Daniela
AU - Mittendorf, Thomas
AU - Wagner, Thomas O.F.
AU - Reimann, Andreas
AU - Graf Von Der Schulenburg, J. Matthias
PY - 2009/7
Y1 - 2009/7
N2 - Purpose: : Main objective of this study is to assess and evaluate resourceuse in outpatient treatment of cystic fibrosis (CF) in Germany and to comparethis with current reimbursement. Methods: Results: Conclusion: Key Words: MedKlin 2009;104:529-35. Methods: : Outpatient treatment was evaluated in sevendifferent CF centers.Clinical patient data, resource use, and time consumptionwere recorded in 2006. A micro-costing approach was used to price resource usedata. Results: : Mean costs of 488 Euros per patient (n = 326) and quarteroccurred. Remuneration (252 Euros per patient/quarter) covered only 52% of thetotal costs. Furthermore, a considerable time and financial burden for patientsas well as decreasing quality of life with increasing age were found. Costs formedication came to 21,604 Euros per patient/year. Conclusion: : Human resourcesin German CF centers today already are below the requirements set by theEuropean consensus for standards of CF care. It will be crucial in assuring ahigh level of patient care to reach a cost-covering reimbursement scheme in Germany.
AB - Purpose: : Main objective of this study is to assess and evaluate resourceuse in outpatient treatment of cystic fibrosis (CF) in Germany and to comparethis with current reimbursement. Methods: Results: Conclusion: Key Words: MedKlin 2009;104:529-35. Methods: : Outpatient treatment was evaluated in sevendifferent CF centers.Clinical patient data, resource use, and time consumptionwere recorded in 2006. A micro-costing approach was used to price resource usedata. Results: : Mean costs of 488 Euros per patient (n = 326) and quarteroccurred. Remuneration (252 Euros per patient/quarter) covered only 52% of thetotal costs. Furthermore, a considerable time and financial burden for patientsas well as decreasing quality of life with increasing age were found. Costs formedication came to 21,604 Euros per patient/year. Conclusion: : Human resourcesin German CF centers today already are below the requirements set by theEuropean consensus for standards of CF care. It will be crucial in assuring ahigh level of patient care to reach a cost-covering reimbursement scheme in Germany.
KW - Ambulatory care
KW - Cost analysis
KW - Cystic fibrosis
KW - Medication
KW - Quality of life
UR - http://www.scopus.com/inward/record.url?scp=70349987504&partnerID=8YFLogxK
U2 - 10.1007/s00063-009-1112-9
DO - 10.1007/s00063-009-1112-9
M3 - Review article
C2 - 19618138
AN - SCOPUS:70349987504
VL - 104
SP - 529
EP - 535
JO - Medizinische Klinik
JF - Medizinische Klinik
SN - 0723-5003
IS - 7
ER -